Literature DB >> 20221580

[PET/CT imaging of atherosclerotic blood vessel alterations].

A Rominger1, C Rist, K Nikolaou, M F Reiser, P Bartenstein, M Hacker, T Saam.   

Abstract

Atherosclerosis is a chronic inflammatory disease of middle sized and large vessels with sequelae comprising the most frequent causes of death in the Western world. Modern imaging modalities are being introduced for the study of atherosclerosis with emphasis on the detection of vulnerable plaques. The hybrid imaging method PET/CT presents advantages for the localization of vulnerable plaques based on the uptake of various molecular imaging agents indicative of inflammatory processes. Using semiquantitative image analysis fluorodeoxyglucose (FDG) uptake in large peripheral vessels has been identified in a series of 21 patients, who were scanned first with the previous generation of PET/CT scanner and subsequently with a new generation apparatus, after a mean interval of 6.5 months. The mean ratio of FDG uptake in the walls of eight large vessels to the blood-pool activity (TBR) was nearly identical in the two PET/CT sessions (TBR(1) 1.26 versus TBR(2) 1.28; p=n.s.), indicating independence of the TBR endpoint from the particular instrumentation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221580     DOI: 10.1007/s00117-009-1969-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  51 in total

1.  Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis.

Authors:  Bas L J H Kietselaer; Chris P M Reutelingsperger; Guido A K Heidendal; Mat J A P Daemen; Werner H Mess; Leonard Hofstra; Jagat Narula
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

2.  Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis.

Authors:  I Virgolini; C Müller; P Fitscha; P Chiba; H Sinzinger
Journal:  Prog Clin Biol Res       Date:  1990

Review 3.  The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment.

Authors:  Tobias Saam; Thomas S Hatsukami; Norihide Takaya; Baocheng Chu; Hunter Underhill; William S Kerwin; Jianming Cai; Marina S Ferguson; Chun Yuan
Journal:  Radiology       Date:  2007-07       Impact factor: 11.105

4.  Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study.

Authors:  William S Kerwin; Kevin D O'Brien; Marina S Ferguson; Nayak Polissar; Thomas S Hatsukami; Chun Yuan
Journal:  Radiology       Date:  2006-09-11       Impact factor: 11.105

5.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

6.  18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.

Authors:  Axel Rominger; Tobias Saam; Sarah Wolpers; Clemens C Cyran; Michael Schmidt; Stefan Foerster; Konstantin Nikolaou; Maximilian F Reiser; Peter Bartenstein; Marcus Hacker
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

Review 7.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

8.  Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.

Authors:  Iina Laitinen; Antti Saraste; Eliane Weidl; Thorsten Poethko; Axel W Weber; Stephan G Nekolla; Pia Leppänen; Seppo Ylä-Herttuala; Gabriele Hölzlwimmer; Axel Walch; Irene Esposito; Hans-Jürgen Wester; Juhani Knuuti; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-13       Impact factor: 7.792

9.  Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.

Authors:  Farouc A Jaffer; Dong-Eog Kim; Luisa Quinti; Ching-Hsuan Tung; Elena Aikawa; Ashvin N Pande; Rainer H Kohler; Guo-Ping Shi; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

10.  Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events.

Authors:  Benoît Paulmier; Michèle Duet; Raphaël Khayat; Nadia Pierquet-Ghazzar; Jean-Pierre Laissy; Christophe Maunoury; Florent Hugonnet; Elisabeth Sauvaget; Ludovic Trinquart; Marc Faraggi
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

View more
  1 in total

1.  [New aspects of MRI for diagnostics of large vessel vasculitis and primary angiitis of the central nervous system].

Authors:  T Saam; M Habs; C C Cyran; J Grimm; T Pfefferkorn; U Schüller; M F Reiser; K Nikolaou
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.